Hamps Bio Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | December 13, 2024 to December 17, 2024 |
| Listing Date | - |
| Face Value | ₹ 10 per share |
| Price Band | ₹ 51 per share |
| Lot Size | 2,000 Shares |
| Total Issue Size | 12,20,000 shares (aggregating up to ₹ 6.22 Cr) |
| Fresh Issue | 12,20,000 shares (aggregating up to ₹ 6.22 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Shareholding pre issue | 31,36,000 |
| Shareholding post issue | 43,56,000 |
| Market Maker portion | 62,000 shares Pure Broking |
About Hamps Bio Limited IPO
Hamps Bio Limited, incorporated in 2007, is a dynamic company that is engaged in marketing & distribution of a diverse pharmaceutical product range, like syrups, injectables, capsules, oils, nutritional supplements and more. Having a steadfast commitment to innovation and quality, Hamps BIO has also established itself as a trusted name within the pharmaceutical industry.
Distribution Network:
Hamps Bio Limited boasts an extensive distribution network encompassing approximately 50 distributors and varied e-commerce platforms. The products they offer are available on varied reputable online marketplaces, including Amazon in the EU, Canada, and the US. Apart from that, the products are also available in India on Jio Mart and Flipkart. Maintaining expansive reach with the offered products ensures that the pharma offerings by Hamps Bio remain accessible to a broad consumer range. Their pharma products are sold across the eight states and the Indian Union territories. Moreover, their freeze-dried and frozen products have a broader geographical reach, extending to 22 states and union territories of 6 countries.
Business Segments:
Hamps Bio Limited's operations have been strategically divided into two major segments:
Pharmaceuticals
Operating under the "Hamps" brand, the company's pharmaceutical division delivers a comprehensive product array. Such a segment includes syrups, tablets, injectables, capsules, and also powders. All of it is meticulously crafted to meet high standards of both safety and efficacy.
Freeze-dried and Frozen Products
The FMCG division of the company focuses on freeze-dried & frozen items. These are marketed under the "FzyEzy" brand. Hamps Bio today operates via both B2C and B2B models, offering products under the brand and even engaging within contract manufacturing. The freeze-dried & frozen product line includes varied options like strawberries, mango, jamun and chikoo powder, catering to both international and domestic demands.
To summarize, Hamps Bio Limited continues its expansion today by having a footprint in not just pharmaceutical but also FMCG sectors. It is driven by innovation & customer satisfaction.
Hamps Bio IPO Overview:
- Issue Type: Fixed Price Issue IPO
- IPO Size: ₹6.22 crores
- Fresh Issue: 12.2 lakh shares
- Price Per Share: ₹51
- Minimum Lot Size: 2000 shares
- IPO Opening Date: December 13, 2024
- IPO Closing Date: December 17, 2024
- Book Running Lead Managers: Marwadi Chandarana Intermediaries Brokers Pvt. Ltd.
- Registrar: Bigshare Services Pvt. Ltd.
- Market Maker: Pure Broking
Hamps Bio IPO Objectives:-
- The Company intends to use its proceeds as follows:
- 1. Purchase of plant & machinery for FMCG division.
- 2. Enhancing the visibility and awareness of the brand.
- 3. General corporate purposes.
Hamps Bio Limited IPO Financial Information
Latest Revenue
436.42
₹ Crore
Profit After Tax
34.08
₹ Crore
Net Worth
370.78
₹ Crore
Total Borrowing
138.31
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing | ||||
|---|---|---|---|---|---|---|---|---|---|
| 30 Oct 2024 | 644.00 | 436.42 | 34.08 | 370.78 | 138.31 | ||||
| 31 Mar 2024 | 514.77 | 650.13 | 50.07 | 337.42 | 104.52 | ||||
| 31 Mar 2023 | 395.87 | 558.49 | 35.90 | 136.30 | 173.77 | ||||
| 31 Mar 2022 | 364.31 | 534.46 | 12.15 | 100.57 | 204.31 | ||||
| Amount in ₹ Crore | |||||||||
Hamps Bio Limited Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 21.14% |
| ROCE | 18.31% |
| RoNW | 14.84% |
| Debt/Equity | 0.31 |
| P/BV | 2.96 |
| PAT Margin (%) | 7.73 |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Expert Leadership and Industry Experience Driving Strategic Business Growth.
Distribution Network with an Expansive E-Retailing Presence.
Wide and diversified range of products.
Diversified, global customer base with long-standing relationships.
Wide Geographical Presence.
Brand Identity.
Hamps Bio Limited IPO Timeline
| IPO Open Date | Friday, December 13, 2024 |
| IPO Close Date | Tuesday, December 17, 2024 |
| Basis of Allotment | Wednesday, December 18, 2024 |
| Initiation of Refunds | Thursday, December 19, 2024 |
| Credit of Shares to Demat | Thursday, December 19, 2024 |
| Listing Date | Friday, December 20, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 17, 2024 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹102,000 |
| Retail (Max) | 1 | 2000 | ₹102,000 |
| HNI (Min) | 2 | 4000 | ₹204,000 |